Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM)

Sinning, Mariana; Letelier, René; Rosas, Carlos; Fuenzalida, Marcela; Lemus, David.
Biol. Res ; 45(2): 135-138, 2012. tab
Artículo en Inglés | LILACS | ID: lil-648572

Documentos relacionados

  1. Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM).
  2. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.
  3. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
  4. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
  5. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
  6. Cerebrospinal fluid protein dynamic driver network: At the crossroads of brain tumorigenesis.
  7. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
  8. GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.
  9. IVIM analysis of brain tumors: an investigation of the relaxation effects of CSF, blood, and tumor tissue on the estimated perfusion fraction.
  10. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.